Big pharma steps up access, but uneven progress made: report

16-11-2022

Staff Writer

Big pharma steps up access, but uneven progress made: report

Irina Anosova / Shutterstock.com

Licensing of COVID-19 treatments has shifted to include other medicines and treatment areas | World’s largest pharma companies still “consistently overlook the poorest countries” | Report offers strategy to improve access.


Access to Medicine Foundation, access to medicine, big pharma, voluntary licensing, access plans, GSK, Johnson & Johnson, AstraZeneca, Novartis

LSIPR